Cough variant asthma
Conditions
Interventions
Healthy control group:None
Western medicine group:Montelukast
Chinese medicines group:Huanglong mixture
Sponsors
Nanjing Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: (1) 3-18 years old; (2) In line with the diagnostic standards of traditional Chinese and western medicine, the syndrome differentiation of traditional Chinese medicine was wind heat trapping phlegm; (3) Stop bronchodilators and/or hormones 2 weeks before starting treatment; (4) Informed consent of the guardian of the child.
Exclusion criteria
Exclusion criteria: (1) Patients who do not meet the above diagnostic criteria of traditional Chinese and Western medicine, or whose age range is not 3-18 years old; (2) those allergic to two groups of drugs; (3) Patients with other typical primary diseases, such as liver disease, kidney disease, blood disease, cardiovascular disease and metabolic disease, which may affect the results of this clinical trial; (4) Patients who did not use the drug according to the standard, could not judge the efficacy or had incomplete data affecting the efficacy evaluation; (5) Participants in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1/FVC;EO%;IgE; | — |
Secondary
| Measure | Time frame |
|---|---|
| PEF;Blood routine;MEF25%;FeNO;NEUT%; | — |
Countries
China
Contacts
Public ContactLong Hongyan
Nanjing Hospital of Chinese Medicine
Outcome results
None listed